Physician profile
Beth K Levy
NPI 1558317461
$205.71
in general payments reported to CMS, 2019-2025
10 companies · $17.27 in 2025
The $17.27 reported for 2025 was less than what a typical Cytopathology provider received nationally (typical 2025 total: $55.75).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.00 · 2020: $11.92 · 2022: $49.81 · 2024: $33.71 · 2025: $17.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $53.37 | 2019 | |
| Medtronic, INC. | $33.71 | 2024 | Interstim |
| Myovant Sciences INC. | $21.59 | 2022 | |
| Olympus America INC. | $17.27 | 2025 | Itind System |
| Otsuka America Pharmaceutical, INC. | $14.91 | 2019 | |
| Merck Sharp & Dohme LLC | $14.75 | 2022 | |
| Seqirus USA INC | $13.47 | 2022 | |
| Convatec INC. | $13.45 | 2019 | |
| Laborie Medical Technologies Corp. | $11.92 | 2020 | |
| Janssen Biotech, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.